BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32620196)

  • 1. Gout epidemiology and comorbidities.
    Singh JA; Gaffo A
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S11-S16. PubMed ID: 32620196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities in gout and hyperuricemia: causality or epiphenomena?
    Sumpter NA; Saag KG; Reynolds RJ; Merriman TR
    Curr Opin Rheumatol; 2020 Mar; 32(2):126-133. PubMed ID: 31876630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.
    Bardin T; Richette P
    BMC Med; 2017 Jul; 15(1):123. PubMed ID: 28669352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
    Sandoval-Plata G; Nakafero G; Chakravorty M; Morgan K; Abhishek A
    Rheumatology (Oxford); 2021 Jul; 60(7):3243-3251. PubMed ID: 33313843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities in patients with crystal diseases and hyperuricemia.
    Sattui SE; Singh JA; Gaffo AL
    Rheum Dis Clin North Am; 2014 May; 40(2):251-78. PubMed ID: 24703346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
    Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
    Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street.
    Karis E; Crittenden DB; Pillinger MH
    South Med J; 2014 Apr; 107(4):235-41. PubMed ID: 24937517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review.
    Bevis M; Blagojevic-Bucknall M; Mallen C; Hider S; Roddy E
    Rheumatology (Oxford); 2018 Aug; 57(8):1358-1363. PubMed ID: 29672754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.
    Nyberg F; Horne L; Morlock R; Nuevo J; Storgard C; Aiyer L; Hines DM; Ansolabehere X; Chevalier P
    Adv Ther; 2016 Jul; 33(7):1180-98. PubMed ID: 27230988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.
    Singh JA; Cleveland JD
    BMC Nephrol; 2019 Mar; 20(1):93. PubMed ID: 30876398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
    Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
    J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls.
    Ferguson LD; Molenberghs G; Verbeke G; Rahimi K; Rao S; McInnes IB; McMurray JJV; Sattar N; Conrad N
    Lancet Rheumatol; 2024 Mar; 6(3):e156-e167. PubMed ID: 38383089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
    Zhu Y; Pandya BJ; Choi HK
    Am J Med; 2012 Jul; 125(7):679-687.e1. PubMed ID: 22626509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hyperuricemia and gout.
    Luk AJ; Simkin PA
    Am J Manag Care; 2005 Nov; 11(15 Suppl):S435-42; quiz S465-8. PubMed ID: 16300457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden and management of gout in a multi-ethnic Asian cohort.
    Chua CKT; Cheung PP; Santosa A; Lim AYN; Teng GG
    Rheumatol Int; 2020 Jul; 40(7):1029-1035. PubMed ID: 31758246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout and its comorbidities in the total population of Stockholm.
    Wändell P; Carlsson AC; Ljunggren G
    Prev Med; 2015 Dec; 81():387-91. PubMed ID: 26500085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years.
    Elfishawi MM; Zleik N; Kvrgic Z; Michet CJ; Crowson CS; Matteson EL; Bongartz T
    J Rheumatol; 2018 Apr; 45(4):574-579. PubMed ID: 29247151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use.
    Novak S; Melkonian AK; Patel PA; Kleinman NL; Joseph-Ridge N; Brook RA
    Curr Med Res Opin; 2007 Mar; 23(3):623-30. PubMed ID: 17355743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of gout and chondrocalcinosis.
    Ciancio G; Bortoluzzi A; Govoni M
    Reumatismo; 2012 Jan; 63(4):207-20. PubMed ID: 22303527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study.
    Janssens HJ; Arts PG; Schalk BW; Biermans MC
    Joint Bone Spine; 2017 Jan; 84(1):59-64. PubMed ID: 27236260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.